bioRxivCell Biology
The Kinase Chemogenomic Set (KCGS): An open science resource for kinase vulnerability identification
C. I. Wells, H. Al-Ali, D. M. Andrews, C. R. M. Asquith, A. D. Axtman, M. Chung, I. Dikic, D. Ebner, J. Elkins, P. Ettmayer, C. Fischer, M. Frederiksen, N. S. Gray, S. B. Hatch, S. Knapp, S. Lee, U. Lucking, M. Michaelides, C. E. Mills, S. Muller, D. Owen, A. Picado, K. Ramadan, K. S. Saikatendu, M. Schroder, , D. H. Drewry
Abstract
We describe the assembly and annotation of a chemogenomic set of protein kinase inhibitors as an open science resource for studying kinase biology. The set only includes inhibitors that show potent kinase inhibition and a narrow spectrum of activity when screened across a large panel of kinase biochemical assays. Currently, the set contains 187 inhibitors that cover 215 human kinases. The kinase chemogenomic set (KCGS) is the most highly annotated set of selective kinase inhibitors available to researchers for use in cell-based screens.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Progress Towards a Public Chemogenomic Set for Protein Kinases and a Call for Contributions
D. H. Drewry, C. I. Wells, … T. M. Willson·bioRxiv·Jan 31, 2017
- An optimal set of inhibitors for Reverse Engineering via Kinase Regularization.
Scott Rata, Jonathan Scott Gruver, … Leonid Peshkin·bioRxiv·Sep 26, 2020
- Exploring the understudied human kinome for research and therapeutic opportunities
Nienke Moret, Changchang Liu, … Peter Karl Sorger·bioRxiv·Apr 2, 2020
- PKIS Deep Dive Yields a Chemical Starting Point for Dark Kinases and a Cell Active BRSK2 Inhibitor
T. Y. Tamir, D. H. Drewry, … A. D. Axtman·bioRxiv·Jun 15, 2020
- In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases
C. I. Wells, N. R. Kapadia, … D. H. Drewry·bioRxiv·May 14, 2017
- Predicting kinase inhibitors using bioactivity matrix derived informer sets
H. Zhang, S. S. Ericksen, … M. A. Newton·bioRxiv·Jan 28, 2019